Alessio Redaelli
News
23.09.2023
Focus on hyperpigmentation:
Treatment options and combination therapy in everyday practice Hyperpigmentation plays a major role in the daily routine of dermatologists. Solar radiation, stress and various noxae are regarded as triggers for […]
07.02.2024
Interview with David Eccleston: How to achieve the best results in the treatment with neuromodulators
Dr. David Eccleston is the Clinical Director of MediZen, founded in 1999 along with his wife Annie, a registered nurse. Dr Eccleston is an International Key Opinion Leader in the […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]